GITNUXSOFTWARE ADVICE
Biotechnology PharmaceuticalsTop 10 Best Structural Biology Services of 2026
Ranked top 10 structural biology services for technical teams, comparing major providers and contract partners including Charles River and WuXi AppTec.
How we ranked these tools
Core product claims cross-referenced against official documentation, changelogs, and independent technical reviews.
Analyzed video reviews and hundreds of written evaluations to capture real-world user experiences with each tool.
AI persona simulations modeled how different user types would experience each tool across common use cases and workflows.
Final rankings reviewed and approved by our editorial team with authority to override AI-generated scores based on domain expertise.
Score: Features 40% · Ease 30% · Value 30%
Gitnux may earn a commission through links on this page — this does not influence rankings. Editorial policy
Viva Biotech is the best fit if you’re outsourcing experimental execution and need accountable, interpretation-ready structural outputs with solid delivery, whereas ZoBio works better when you want structure-solving workflows and refined model deliverables from a specialist.
Editor’s top 3 picks
Three quick recommendations before you dive into the full comparison below — each one leads on a different dimension.
Viva Biotech
Single managed workflow that coordinates complex and membrane targets through data collection and model interpretation deliverables.
Built for fits when teams outsource experimental execution and want interpretation-ready structural outputs with accountable delivery..
Charles River Laboratories
Editor pickOperational cryo-electron microscopy delivery with structured handoffs from sample readiness to dataset reporting.
Built for fits when labs outsource cryo-electron microscopy execution and want predictable, report-ready outcomes..
WuXi AppTec
Editor pickSingle-program structural execution designed to carry structure findings into downstream discovery iterations.
Built for fits when discovery programs need multiple structural modalities and tight feedback into engineering..
Comparison Table
Viva Biotech
enterprise_vendorViva Biotech provides protein production, X-ray crystallography, cryo-electron microscopy, and integrated discovery services.
Single managed workflow that coordinates complex and membrane targets through data collection and model interpretation deliverables.
Viva Biotech supports structural biology requests that require careful experimental design and iterative refinement of data quality before model building. The engagement model is geared toward producing analysis-ready artifacts for downstream teams, including interpretable structures and documentation that enables reuse in follow-on modeling and validation steps. Coverage spans both protein and nucleic acid targets, with added fit for membrane protein and macromolecular complex programs that usually need tighter handling across buffer, construct, and data acquisition constraints.
A key tradeoff is that deep customization for unusual instrument setups or niche pipelines may require extra coordination time because Viva Biotech is organized around repeatable service workflows. Viva Biotech fits teams that need throughput across multiple targets and want one accountable partner for experimental execution plus structural interpretation output suitable for internal decision-making and publication preparation.
- +End-to-end handling from experimental planning to interpretive structure outputs
- +Experience with protein–ligand and complex workflows that need coordinated iteration
- +Coverage for membrane protein programs where sample constraints drive outcomes
- –Workflow customization for atypical pipelines needs more lead time
- –Integration depth with internal modeling stacks depends on the agreed deliverables
Structural biology core
Protein–ligand complex structure campaign
Faster structure-informed chemistry decisions
Membrane protein group
Membrane target structure pipeline
Improved odds of usable density
Show 1 more scenario
Drug discovery team
Protein–protein interaction complex
Clearer binding and interfaces
Coordinates complex preparation and structural interpretation to support mechanism-focused design.
Best for: Fits when teams outsource experimental execution and want interpretation-ready structural outputs with accountable delivery.
Charles River Laboratories
enterprise_vendorCharles River Laboratories provides structural biology, protein sciences, biophysics, and integrated discovery research services.
Operational cryo-electron microscopy delivery with structured handoffs from sample readiness to dataset reporting.
Structural biology teams engage Charles River Laboratories when experiments require coordinated wet-lab operations and consistent data capture across projects, not just method advice. Delivery typically covers upstream construct and sample readiness support, followed by cryo-electron microscopy execution and structured scientific reporting tied to the collected datasets. Engagement quality is driven by repeatable lab procedures, staffing continuity, and clear progression gates between sample readiness and data collection.
A tradeoff appears when a program needs highly specialized analysis pipelines or bespoke algorithm customization beyond standard analysis packages. Teams fit better when requirements can be expressed as deliverable outcomes, such as model-quality interpretation and microscopy-derived findings, rather than as a requirement to redesign the full reconstruction workflow. A common usage situation is an external sponsor that must keep internal R&D bandwidth focused while outsourcing microscopy execution and associated interpretation work.
- +Cryo-electron microscopy execution with disciplined wet-lab handoffs
- +Delivery teams designed for consistent study progression and reporting
- +Works well for protein–ligand and complex-centric experimental programs
- +Clear coordination between sample readiness and microscopy data collection
- –Limited flexibility when analysis needs require custom pipeline engineering
- –Integration into internal automation stacks may require extra project management
- –Turnaround depends on sample readiness gates and preparation outcomes
- –Most gains accrue when work can be scoped to standard deliverables
Drug discovery structural teams
Outsource cryo-EM complex data generation
Reduced internal execution burden
Biotech research operations
Standardize study execution across batches
More predictable run-to-run results
Show 1 more scenario
Institutional academic labs
Scale microscopy work without core staffing
Higher experiment throughput
Transfer microscopy execution and associated reporting to a staffed contract team for throughput.
Best for: Fits when labs outsource cryo-electron microscopy execution and want predictable, report-ready outcomes.
WuXi AppTec
enterprise_vendorWuXi AppTec offers protein sciences, structural biology, biophysical screening, and integrated drug discovery services.
Single-program structural execution designed to carry structure findings into downstream discovery iterations.
WuXi AppTec operates across X-ray crystallography, cryo-EM single-particle reconstruction, and NMR spectroscopy workflows that cover soluble proteins and multiple sample contexts. It also supports structure-to-program transitions that connect experimental results to protein engineering, complex characterization, and medicinal chemistry needs. Teams benefit when the same program requires repeated cycles of expression optimization, data collection, and model refinement rather than one-off structures.
A practical tradeoff is that broad modality coverage can dilute focus on one narrow pipeline versus boutique specialists, especially when a project needs extreme throughput or very specific phasing choices. WuXi AppTec is a good fit when a sponsor wants a single accountable execution path for multiple structure formats across a program, such as a protein–ligand series plus complex confirmation.
- +Multi-modality coverage across cryo-EM, X-ray crystallography, and NMR
- +Program-level continuity from structure output into downstream discovery work
- +Refinement and interpretation pipelines that support iterative engineering cycles
- +Handles both soluble and challenging targets through workflow breadth
- –Broad coverage can slow specialized decisions for uncommon experimental needs
- –Execution pace can depend on sample readiness and iterative optimization cycles
- –Choice among phasing and refinement paths may require close project governance
- –Coordination overhead increases when projects mix modalities and complex types
Discovery leadership teams
Need structures for parallel design tracks
Fewer transition delays
Biologics teams
Confirm protein–protein complex models
Clear interface hypotheses
Show 2 more scenarios
Protein engineering teams
Iterate expression for structure feasibility
Higher success rate
Structured cycles connect target construct changes to re-run structural data collection and model building.
Translational discovery groups
Support structure-driven optimization
Actionable model guidance
Structure outputs feed downstream chemistry and biologics work to guide next-round optimization choices.
Best for: Fits when discovery programs need multiple structural modalities and tight feedback into engineering.
Pharmaron
enterprise_vendorPharmaron offers protein sciences, structural biology, biophysics, medicinal chemistry, and integrated drug discovery research.
End-stage deliverables packaged for deposition readiness across both crystallography and cryo-EM model refinement cycles.
Pharmaron delivers structural biology services focused on taking projects from sample-ready biology through structure-ready outputs for deposition. Its work spans X-ray crystallography and cryo-electron microscopy workflows, with end-stage deliverables framed around atomic models and map-level outputs.
The offering also supports membrane-protein and protein–ligand programs, which typically require tighter iteration loops between expression, purification, data collection, and refinement. Engagement quality is geared toward contract execution where timelines, format control, and revision cycles matter as much as raw instrument time.
- +Delivers end-stage crystallography outputs suitable for structure validation workflows
- +Supports cryo-electron microscopy programs that need iterative model refinement
- +Handles protein–ligand and membrane-protein work where project iteration is routine
- +Produces structure-ready deliverables aligned to deposition formats
- –Automation and API integration surface is not a documented strength for buyers
- –Governance controls for multi-project RBAC and audit logging are not highlighted
- –Iterative microscopy data work can extend cycles when initial specimens underperform
- –Workflow configurability appears less transparent than for buyers needing fine-grained pipelines
Best for: Fits when teams need contract structural biology execution with repeated refinement cycles and format-controlled deliverables.
Evotec
enterprise_vendorEvotec provides structural biology, protein production, biophysical screening, fragment discovery, and integrated drug research.
Cross-modality delivery that links measured experimental observables to model refinement for target and ligand decisions.
Evotec provides structural biology service delivery that couples experimental structure generation with model building and refinement work suitable for downstream discovery decisions.
The capability mix includes X-ray crystallography, cryo-electron microscopy, and NMR-style characterization, which helps teams reduce the risk of depending on a single experimental modality.
Protein–ligand complex studies are handled with an emphasis on translating structure outputs into interpretable atomistic models for subsequent rounds of design.
- +Multi-modal structural biology support covers X-ray, cryo-EM, and NMR-style studies
- +Atomistic refinement work ties outputs to measured experimental observables
- +Experience with protein–ligand complex structures supports medicinal chemistry handoffs
- +Program-level coordination reduces cross-team rework between experiments and modeling
- –Workflow coordination across modalities can lengthen iteration cycles
- –Automation and API surfaces are not presented as a primary integration mechanism
- –Governance artifacts like RBAC and audit log tooling are not emphasized for external teams
- –Membrane protein programs often depend on upstream construct and expression success
Best for: Fits when a discovery program needs multi-modal structural evidence and refinement across atomistic models.
ZoBio
specialistZoBio delivers protein production, biophysical characterization, X-ray crystallography, and structure-guided medicinal chemistry.
Project-centered delivery that packages electron density map and refinement outputs for downstream validation and modeling.
ZoBio delivers structural biology services focused on taking projects from experimental design through structure delivery for teams that need outsourced wet lab execution. Its distinct angle is end-to-end handling of common structure-solving workflows across protein–ligand and protein–protein targets, then packaging results for downstream modeling and validation steps.
The service framing centers on operational coordination for crystallography and EM style pipelines rather than offering a software-only automation interface. Deliverables typically include processed experimental outputs like electron density maps and refined atomic models ready for deposition workflows.
- +End-to-end operational handling for common protein structure workflows
- +Clear deliverables handoff from experimental data through refined models
- +Good fit for protein–ligand and protein–protein structure objectives
- +Practical focus on map generation and refinement outputs usable downstream
- –Limited public detail on API, automation hooks, and integration patterns
- –Less visibility into internal data model and schema choices for outputs
- –Workflow depth can vary by target class and requires planning discipline
- –Turnaround control depends on external sample and instrument constraints
Best for: Fits when teams need outsourced execution of structure-solving workflows and refined model deliverables.
SARomics Biostructures
specialistSARomics Biostructures provides protein production, biophysical assays, X-ray crystallography, and structure-based design support.
Refinement and validation are treated as first-class outputs that convert raw microscopy or diffraction outcomes into deposition-ready models.
SARomics Biostructures focuses on outsourced structural biology execution with an emphasis on workflow handoff between experiment planning and structure delivery. The service supports major modalities such as X-ray crystallography and cryo-electron microscopy, with downstream molecular refinement and validation steps included in the engagement.
It also handles protein–ligand and protein–protein structural targets in a way that aligns deliverables to structure publication standards, including deposition-ready formats. Delivery quality is shaped by how consistently SARomics can translate experimental outcomes into usable models and map interpretation artifacts for structure-based decision making.
- +Clear end-to-end path from experimental inputs to refinement outputs
- +Supports X-ray crystallography and cryo-electron microscopy workflows
- +Produces models suited for structure validation and deposition preparation
- +Capable of protein–ligand and protein–protein complex structures
- –Limited transparency on automation depth for high-throughput iteration loops
- –May require structured internal coordination for construct, buffer, and target changes
- –Electron microscopy deliverable specifics can depend on engagement scope
- –Integration beyond deliverables is not presented as an API-led system
Best for: Fits when teams need outsourced structural biology deliverables with refinement and validation carried through to publication-grade models.
Domainex
specialistDomainex provides protein science, X-ray crystallography, biophysics, fragment screening, and structure-guided drug discovery.
Milestone-based execution across structure determination and atomic model delivery for rapid handoff into validation and downstream analysis.
Domainex is a structural biology service provider focused on delivering experiment-to-model outputs that fit crystallography and electron microscopy workflows. The distinctive emphasis is on end-to-end execution for structure determination tasks, including data handling through to atomic modeling and delivery in standard scientific formats.
Teams typically engage Domainex for scoped projects where consistency of output and integration with downstream analysis matters more than internal buildout. The provider’s fit is strongest when a single delivery partner can manage the full structure pipeline and hand results off in a form research groups can directly validate and deposit.
- +End-to-end project delivery reduces handoff gaps between data processing and modeling
- +Outputs align with common structure workflows used in downstream validation and refinement
- +Clear scoping helps teams plan review cycles around specific structural milestones
- +Experienced handling of crystallography and electron microscopy study types
- –Limited transparency on automation tooling and API surfaces for programmatic integration
- –Modeling and refinement depth can be scope-dependent on the agreed deliverables
- –Governance artifacts like audit logs and RBAC are not described for collaborative oversight
- –Throughput and scheduling commitments are not framed as measurable capacity metrics
Best for: Fits when research groups need a delivery partner for structure determination and modeling milestones with standard scientific handoffs.
Medicilon
enterprise_vendorMedicilon provides protein expression, crystallography, cryo-electron microscopy, biophysics, and drug discovery services.
Managed delivery from experimental data to refined structural models and validation outputs across crystallography and microscopy studies.
Medicilon delivers structural biology services that include X-ray crystallography, cryo-electron microscopy workflows, and nucleic-acid structure support through experimental execution and downstream structure modeling. The offering typically centers on converting experimental outputs into interpretable atomic or pseudo-atomic models and documentation artifacts suitable for downstream research.
Medicilon also supports structure refinement and validation steps that align model geometry with experimental evidence. Contract engagement fit is strongest when teams want managed end-to-end delivery across wet lab and modeling handoffs rather than tool-only consulting.
- +End-to-end handoff between experimental workflows and model refinement deliverables
- +Supports multiple structure types spanning proteins and nucleic acids
- +Produces refinement and validation outputs for model geometry review
- +Contract delivery model fits organizations needing managed execution
- –Integration depth for automated pipelines and APIs is not clearly specified
- –Workflow customization for atypical experiments may require iterative scoping
- –Governance controls such as RBAC and audit logs are not described
- –Evidence package depth for complex integrative projects is not explicit
Best for: Fits when project teams need managed structural biology execution through model refinement and validation handoffs.
NanoImaging Services
specialistNanoImaging Services provides contract cryo-electron microscopy, negative-stain imaging, image processing, and reconstruction.
Project execution built around electron microscopy specimen readiness and reconstruction deliverables for downstream modeling.
NanoImaging Services provides contract structural biology work focused on electron microscopy sample preparation and data collection workflows. The service supports upstream specimen handling through microscopy-ready preparation steps and then runs to downstream reconstruction deliverables.
NanoImaging Services is distinct for taking imaging tasks end to end rather than stopping at instrument access. Delivery is oriented toward analysis handoff artifacts that support downstream modeling and validation in external pipelines.
- +End-to-end electron microscopy workflow for managed handoff between preparation and imaging
- +Clear focus on EM-driven structural biology deliverables rather than broad multi-tech coverage
- +Supports iterative specimen handling based on imaging outcomes during project cycles
- +Emphasis on documentation of experimental conditions for reproducible reprocessing
- –Limited fit for projects centered on X-ray crystallography or NMR workflows
- –Automation and API surface are not documented for programmatic provisioning or monitoring
- –Complex integrative workflows can require tighter coordination for model and map alignment
- –Throughput depends on specimen quality, which can prolong cycles for difficult samples
Best for: Fits when EM experiments need managed preparation and reconstruction deliverables for external model building.
Conclusion
After evaluating 10 biotechnology pharmaceuticals, Viva Biotech stands out as our overall top pick — it scored highest across our combined criteria of features, ease of use, and value, which is why it sits at #1 in the rankings above.
Use the comparison table and detailed reviews above to validate the fit against your own requirements before committing to a tool.
How to Choose the Right structural biology
Structural biology services convert experimental measurements into interpretable atomic and molecular models through managed execution and deliverables that connect wet-lab or instrumentation work to refinement and validation outputs. This guide covers Viva Biotech, Charles River Laboratories, and eight other providers that handle cryo-electron microscopy, X-ray crystallography, and NMR-linked workflows at different degrees of end-to-end coordination.
The selection emphasizes how each provider structures handoffs, including dataset reporting from Charles River Laboratories and interpretation-ready structural outputs from Viva Biotech. It also flags where workflow customization, automation, and integration depth show up as delivery constraints across the providers in this list.
Structural biology services that deliver deposition-ready models from experimental data
Structural biology uses experimental observables from cryo-electron microscopy, X-ray crystallography, and NMR to produce electron density maps, model building outputs, and refined structures that support structure validation and downstream decisions. Contract structural biology execution differs most in how delivery teams package interpretation-ready deliverables, how iteration loops are coordinated, and how refinement and validation steps are carried through to final outputs. Viva Biotech is built around a single managed workflow that coordinates complex and membrane targets through data collection and model interpretation deliverables.
Charles River Laboratories focuses on operational cryo-electron microscopy execution with structured wet-lab handoffs that lead to disciplined dataset reporting. WuXi AppTec adds program-level continuity across cryo-EM, X-ray crystallography, and NMR-style modalities that aims to feed structure outputs back into discovery iterations.
Key capabilities that determine usable structural biology outcomes
Structural biology buyers need more than single assay completion. Teams need managed handoffs that carry experimental measurements into interpretable models, validation outputs, and deposition-ready deliverables.
This guide ranks providers by how they structure those handoffs, how they coordinate iteration across modalities, and how consistently they package refinement and reporting so internal teams can review, model, and decide without rebuilding the workflow.
End-to-end workflow coordination for complex and membrane targets
Viva Biotech is built around a single managed workflow that coordinates complex and membrane targets through data collection and model interpretation deliverables. Domainex provides milestone-based structure determination and atomic model delivery that supports standard scientific handoffs.
Operational cryo-EM execution with wet-lab to dataset reporting handoffs
Charles River Laboratories delivers operational cryo-electron microscopy execution with disciplined wet-lab handoffs that end in structured dataset reporting. NanoImaging Services centers electron microscopy specimen readiness and reconstruction deliverables to support downstream model building.
Multi-modality structural execution with program-level continuity
WuXi AppTec runs multi-modality structural execution across cryo-electron microscopy, X-ray crystallography, and NMR-linked workflows with continuity from structure outputs into downstream discovery iterations. Evotec offers cross-modality delivery that links measured experimental observables to atomistic model refinement for target and ligand decisions.
Refinement and validation delivery packaged for deposition readiness
SARomics Biostructures treats refinement and validation as first-class outputs that convert raw outcomes into deposition-ready models across microscopy and diffraction workflows. Pharmaron packages end-stage deliverables for deposition readiness across crystallography and cryo-electron microscopy model refinement cycles.
Deliverables handoff from experimental inputs through refined models
ZoBio packages electron density map and refinement outputs for downstream validation and modeling with clear handoff from experimental data through refined models. Medicilon provides managed delivery from experimental data to refined structural models and validation outputs across crystallography and microscopy studies.
Integration depth and automation surface for multi-project governance
Viva Biotech emphasizes coordinated interpretation-ready outputs where internal modeling stacks depend on agreed deliverables rather than only report snapshots. Pharmaron is not highlighted for API integration surface and governance controls such as multi-project RBAC and audit logging.
How to choose a structural biology service by workflow control and iteration fit
The fastest path to decision-ready structures comes from matching the provider's delivery shape to internal iteration patterns. Some vendors run tightly coordinated end-to-end programs that reduce handoff gaps, while others focus on operational execution with structured reporting that internal teams then analyze.
Selection should separate workflow coordination needs from integration expectations. Viva Biotech and Charles River Laboratories differ most in whether coordination spans complex interpretation deliverables end-to-end or focuses on cryo-EM execution with dataset reporting and handoff structure.
Choose end-to-end interpretation delivery or execution-first handoffs
Viva Biotech coordinates complex and membrane targets into interpretation-ready structural outputs with accountable delivery across the full managed workflow. Charles River Laboratories emphasizes operational cryo-electron microscopy execution with structured wet-lab handoffs that lead to predictable dataset reporting rather than broad analysis customization.
Match provider modality coverage to how the program iterates
WuXi AppTec supports cryo-electron microscopy, X-ray crystallography, and NMR-linked coverage in one structural execution program to maintain program-level continuity. Evotec links measured experimental observables to atomistic refinement for target and ligand decisions but may lengthen iteration cycles when coordinating across modalities.
Prioritize deposition-ready refinement when publication-grade iteration is the goal
Pharmaron focuses on end-stage deliverables for deposition readiness across crystallography and cryo-electron microscopy model refinement cycles. SARomics Biostructures delivers refinement and validation as first-class outputs that convert raw outcomes into deposition-ready models.
Set integration expectations based on documented automation and API strength
Viva Biotech's integration fit depends on agreed deliverables needed by internal modeling stacks, which shifts the integration conversation toward how outputs are packaged. Pharmaron is not highlighted for automation and API integration surface, so internal teams expecting programmatic provisioning and deep governance controls should plan for extra manual coordination.
Use milestone-based delivery when standard handoffs matter more than tight internal automation
Domainex provides milestone-based execution across structure determination and atomic model delivery with outputs aligned to common downstream validation and refinement workflows. ZoBio and Medicilon also emphasize handoff from experimental inputs through refined models, but ZoBio provides less public detail on API and automation hooks.
Who should buy structural biology services from these providers
These services fit teams that need managed execution through refinement and validation deliverables rather than isolated assay reports. Buyers typically need clarity on how dataset reporting and interpretive outputs reach the internal modeling and decision process.
The best match depends on whether the program requires tight multi-modality iteration, interpretation-ready deliverables that reduce internal rework, or operational cryo-electron microscopy execution with predictable dataset reporting and governance boundaries.
Drug discovery groups running iterative protein and ligand programs across multiple structural modalities
WuXi AppTec is designed for program-level continuity from cryo-electron microscopy, X-ray crystallography, and NMR-style outputs into downstream discovery iterations. Evotec ties measured experimental observables to atomistic refinement for target and ligand decisions.
Structural biology teams outsourcing complex or membrane target execution and model interpretation work
Viva Biotech coordinates complex and membrane targets in a single managed workflow that produces interpretation-ready structural outputs. Domainex supports rapid handoff into validation and downstream analysis with milestone-based delivery.
Labs that need deposition-ready refinement cycles with validation carried through to final deliverables
Pharmaron packages end-stage crystallography outputs suitable for structure validation workflows and supports cryo-electron microscopy programs that need iterative model refinement. SARomics Biostructures delivers refinement and validation as first-class outputs that convert raw microscopy or diffraction outcomes into deposition-ready models.
Cryo-EM execution buyers who want disciplined wet-lab to dataset reporting handoffs
Charles River Laboratories structures wet-lab handoffs so datasets arrive as report-ready outcomes with disciplined execution. NanoImaging Services focuses on electron microscopy specimen readiness and reconstruction deliverables to support external model building.
Organizations requiring tight internal automation integration and multi-project governance controls
Viva Biotech’s fit depends on how agreed deliverables map into internal modeling stacks, which shapes integration rather than emphasizing a documented API surface. Pharmaron is not highlighted for governance controls such as multi-project RBAC and audit logging, so buyers should plan for different coordination mechanics.
Common pitfalls when contracting structural biology services
Buyers often assume structural biology outsourcing behaves like a single deliverable handoff. Many providers instead manage iteration across stages, and misunderstanding the stage boundaries leads to rework when internal teams receive partial outputs.
Integration mistakes also occur when buyers expect an automation and API surface that was not presented as a primary capability. Workflow customization constraints can also appear when experimental cases diverge from the provider’s managed execution patterns.
Contracting for datasets without specifying interpretation-ready structural outputs and validation packaging
Viva Biotech targets interpretation-ready structural outputs as part of its managed workflow, while Charles River Laboratories emphasizes cryo-electron microscopy execution that ends in structured dataset reporting. Define whether refined models and validation outputs are required deliverables or only internal next steps.
Expecting high customization without allocating lead time for atypical pipelines
Viva Biotech notes workflow customization for atypical pipelines needs more lead time. Domainex also scopes modeling and refinement depth based on the agreed deliverables, so the contract language must reflect non-standard experimental requirements.
Assuming all multi-modality providers support the same iteration pacing for specialized experiments
WuXi AppTec can slow specialized decisions for uncommon experimental needs because broad coverage must route through program execution patterns. Evotec can lengthen iteration cycles when coordinating workflow coordination across modalities.
Over-relying on automation and API integration when the provider does not highlight an automation surface
Pharmaron is not highlighted for automation and API integration surface and governance controls such as multi-project RBAC and audit logging. ZoBio also has limited public detail on API, automation hooks, and integration patterns, which shifts integration effort back to internal teams.
Treating deposition readiness and refinement coverage as automatic outcomes
SARomics Biostructures explicitly treats refinement and validation as first-class outputs for deposition-ready models. Pharmaron also packages end-stage deliverables for deposition readiness, while ZoBio focuses on electron density map and refinement outputs that require internal validation and modeling follow-through.
How We Selected and Ranked These Providers
We evaluated Viva Biotech, Charles River Laboratories, and eight other structural biology service providers using features at the core delivery stage, not just breadth claims. Features counted for 40% of the ranking, and ease and value each counted for 30%. Viva Biotech received the highest overall score because its managed workflow coordinates complex and membrane targets into interpretation-ready structural outputs with accountable delivery and clear end-to-end packaging from experimental planning to model interpretation deliverables.
Frequently Asked Questions About structural biology
Which provider fits teams that need cryo-electron microscopy execution with documented handoffs?
How do these services handle structure delivery artifacts that downstream scientists can validate and deposit?
What breaks if a program needs a single provider to coordinate both execution and interpretation-grade refinement?
Which provider is best when multiple structural modalities must feed one downstream design iteration loop?
When should a team choose an end-to-end managed workflow across complex and membrane targets?
How do provider handoffs typically map onto wet-lab and modeling responsibilities during onboarding?
Which services are strongest for repeated refinement cycles tied to format-controlled deliverables?
What technical inputs should be clarified up front to prevent mismatches in structure modeling outputs?
Which provider fits nucleic-acid structural biology execution that ends in interpretable models and documentation artifacts?
Tools reviewed
Primary sources checked during evaluation.
Referenced in the comparison table and product reviews above.
- Biotechnology PharmaceuticalsTop 10 Best Molecular Biology Services of 2026
- Construction InfrastructureTop 10 Best Structural Bim Services of 2026
- Biotechnology PharmaceuticalsTop 10 Best Protein Crystallography Services of 2026
- Biotechnology PharmaceuticalsTop 10 Best Cell Biology Software of 2026
- Construction InfrastructureTop 10 Best Structural Software of 2026
Keep exploring
Comparing two specific tools?
Software Alternatives
See head-to-head software comparisons with feature breakdowns, pricing, and our recommendation for each use case.
Explore software alternatives→In this category
Biotechnology Pharmaceuticals alternatives
See side-by-side comparisons of biotechnology pharmaceuticals tools and pick the right one for your stack.
Compare biotechnology pharmaceuticals tools→